Why it matters
The main goal of the ThermoBreast project is to deliver an innovative, non-contact, and harmless screening modality: a medical class 1 device set to change the course of breast cancer detection and patient monitoring.
Although the performance of thermography has been evaluated for breast cancer detection since the 1980s, the unavailability and high cost of sensitive thermal cameras, the non-fixed thermal image acquisition protocol, and the sub-jectivity of manual thermal map interpretation by doctors have hampered its use for breast cancer screening.
ThermoBreast is a new screening technology that combines new, highly sensitive, and affordable infrared cameras that can detect temperature differences up to 0.02°C with recently developed Artificial Intelligence (AI) by ThermoMind LTD to efficiently analyse dynamic thermal patterns over time and detect vascular abnormalities caused by malignancy. This novel approach is a unique opportunity to unlock the potential of dynamic thermography combined with advanced AI analysis for breast cancer detection and diagnosis and develop next-generation breast cancer screening technology for early, risk-free, and accurate detection and prevention of cancer in millions of women in Europe and beyond.
What CPE does
CPE ensures the involvement of patients at different stages (prevention/monitoring) and needs:
– Elucidation of patient needs
– Analysis of ethical, and social aspects applicable to ThermoBreast
In detail CPE:
– Collects stakeholder requirements, recommendations, and policy expectations in workshops and surveys
– Gathers end-user perspectives, i.e., from patients with surveys and focus groups.
– Prepares a White Paper, which will include recommendations on future guidelines and international regulations based on results from the
– Organises the final event at the European Parliament
– Explores the required explainability of the ThermoBreast screening process and modality to enable a trustworthy solution. Create (user
journey) scenarios with personas (one for each relevant stakeholder group represented by CPE)
– Raises awareness of and gains interest in the project using CPEs and other partici-pants’ established networks and social media channels
– Prepares regular newsletters and press releases.
– Distributes printed materials to the project stakeholders
accelopment Schweiz AG
Technion, Faculty of Computer Science
TU Munich, Chair of Biological Imaging
University Medical Center Groningen, Department of Health Sciences
Vrije Universiteit Brussel, Studies in Media, Inno-vation, and Technology
Cancer Patients Europe
Hadassah Medical Center, Sharett Institute of Oncology.
Institut Gustav Roussy, Department of Medical Im-aging
Hospital of Lithuanian University of Health Sciences Kaunas Clinics, Departments of Oncology and Hematology and Radiology
Sheba Medical Center, Suzanne Levy-Gertner On-cogenetics Unit Prof. Dr. Eitan Fredman
University College Cork, Regional Cancer Centre
University Hospital Heidelberg, Department of Ob-stenetrics and Gynecology
Univerzitetni Klinicni Center Maribor, Department of Oncology
University of Oxford, Department of Oncology
Type of Action
HORIZON-MISS-2021-CANCER-02-01: Develop new methods and technologies for cancer screening and early detection
12.12 million euros
Lead Coordinator or Main Proposer